Navigating DMF Registration in China with Rephine

REPHINE SPEECH MARKS OPEN GXPCONSULTANCY

We have been working with Rephine for many years on multiple projects, and their expertise, professionalism, and deep understanding of regulatory requirements never fail to impress us. Their guidance throughout the DMF submission was key for our success.

REPHINE SPEECH MARKS CLOSE GXPCONSULTANCY

About this Case Study

An international API manufacturer partnered with Rephine to navigate China’s complex Drug Master File (DMF) submission process. Rephine’s cross-border team ensured compliance with NMPA guidelines, provided accurate translations, acted as the local regulatory agent, and managed CDE deficiency responses—streamlining approval.

The result was a fully compliant DMF and accelerated market access, supported by Rephine’s dual-region expertise.

“Rephine’s deep regulatory knowledge and responsiveness were crucial to our successful approval in China.”

— Panreac Quimica

Learn how Rephine can simplify your market entry and download the full case study now.

 

Download the Case Study

View other our other resources and company news

GMP Raising the bar Blog series Header image May 25 Blog

Building Resilient Pharmaceutical Supplier Ecosystems

In today's volatile landscape, traditional supplier qualification is no longer enough. Learn how pharma companies can build resilient supplier ecosystems through risk-based strategies, real-time monitoring, ...
Read More
CPV Header image blog apr 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

IT Quality Assurance plays a pivotal role in the life sciences sector, ensuring systems are validated, compliant, and audit-ready. Learn how pharma companies can meet ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

Artificial intelligence and data analytics are reshaping pharmaceutical GMP compliance—but not all innovations are audit-ready. This article explores proven AI use cases, regulator expectations, and ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Risk-Based Auditing: Smarter GxP Compliance with Limited Resources

In today’s pharma landscape, risk-based auditing enables smarter supplier oversight by aligning audit efforts with risk. Discover the benefits, regulatory backing, and how Rephine helps ...
Read More
Pharma equipment qualification hero image Case Study

Pharmaceutical Equipment Requalification Case Study

See how Rephine helped a global pharma company streamline equipment requalification across complex sites with a scalable, risk-based approach aligned with Annex 15.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Continuous Inspection Readiness Beyond Mock Audits

Traditional mock audits aren’t enough. With rising unannounced inspections, pharmaceutical and biotech firms must embrace continuous inspection readiness. This article explores how to embed compliance ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

How Rephine Accelerates Digital QMS Transformation in Pharma

Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
CPV Header image blog apr 25 Blog

Threat Modelling in Medical Devices: STRIDE for MDR/IVDR Cybersecurity Compliance

Understand how STRIDE and other threat modelling techniques help medical device manufacturers meet MDR/IVDR cybersecurity requirements—plus real-world examples and expert insights.
Read More
Medical Device Guide

Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper

Understand how to embed cybersecurity into the medical device lifecycle with this expert guide from Rephine. Includes MDR/IVDR, FDA, and IMDRF guidance on SRM, threat ...
Read More
Contact Us